Michaela Kneissel
4Patents
1h-index
11Co-inventors
41Inventor score
Filing activity: Oct 10, 2008 → Feb 26, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7879322B2 | Compositions and methods for use for antibodies against sclerostin | Physics | 25 | Active |
| US10961305B2 | Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfecta | Chemistry; Metallurgy | 1 | Active |
| US10028955B2 | FGFR inhibitor for use in the treatment of hypophosphatemic disorders | Human Necessities | 1 | Active |
| US12173058B2 | Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfecta | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.